ABSTRACT

In this book, recognized industry experts and regulatory inspectors from the world's pharmaceutical manufacturing regions provide stability requirements in all the major markets and discuss all aspects of stability testing and biotechnology. Participants in the ICH debates interpret the ICH guidelines. Other discussions focus on European requirements, the ICH initiatives, the US SUPAC initiative, matrixing and bracketing approaches from the cGMP and FDA perspective, and stability requirements in Japan, Australia, and WHO. Stress programs, testing of preservatives, and physical stability topics are addressed as well as various protocols and statistical approaches.

chapter 1|13 pages

The ICH Stability Guideline

chapter |26 pages

Guideline for Industry 1

Stability Testing of new Drug Substances and Products 2

chapter |5 pages

Guideline for Industry 1

Quality of Biotechnological Products: Analysis of the Expression Construct in Cells Used for Production of R-DNA Derived Protein Products

chapter |10 pages

Guideline for Industry 1

Quality of Biotechnological Products: Stability Testing of Biotechnological/Biological Products

chapter 2|13 pages

Photostability Testing

chapter 12|7 pages

Stability Testing for Australia